Immunohistochemical staining of the mismatch repair gene, hMSH2, and survival in patients with ovarian carcinoma

European Journal of Gynaecological Oncology

Volumn 21, Issue 3, 2000, Pages 237-240

  Geisler, J P ^a,c   Geisler, Hans E ^a,b   Miller, G A ^c   Wiemann, M C ^b   Zhou, Z ^c   Crabtree, W ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Vincent Hospitals and Health Services   (United States)

^c NONE   (United States)

Author keywords

hMSH2; Mismatch repair; Ovarian carcinoma

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DNA REPAIR; FEMALE; FOLLOW UP; GENE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PROGNOSIS; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; STAINING AND LABELING;

EID: 0033910780     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Carethers J. M., Hawn M. T., Chauhan D. P., Luce M. C., Marra G., Koi M., Boland C. R.: "Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N-prime-nitro-N-nitrosoquanidine". J. Clin. Invest., 1996, 98, 199.
2. Acbi S., Kurdi-Haidar B., Gordon R., Cenni B., Zheng H., Fink D., Christen R. D. et al.: "Loss of DNA mismatch repair in acquired resistance to cisplatin". Cancer Res., 1996, 56, 3087.
3. Fujita M., Enomoto T., Yoshino K., Nomura T., Buzard G. S., Inouc M., Okudaira Y.: "Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer". Int. J. Cancer, 1995, 64, 361.
4. Karran P.: "Appropriate partners make good matches". Science, 1995, 268, 1857.
5. Lairmore T. C., Norton J. A.: "Advances in molecular genetics". Am. J. Surg., 1997, 173, 37.
6. Boyd J.: "Molecular genetics of hereditary ovarian cancer". Oncology, 1998, 12, 399.
7. Lynch H. T., Casey M. J., Lynch J., White T. E., Godwin A. K.: "Genetics and ovarian carcinoma". Sem. Oncol., 1998, 25, 265.
8. Fishel R., Wilson T.: "MutS homologs in mammalian cells". Cur Op Genet Develop, 1997, 7, 105.
9. Wilson T. M., Ewel A., Duguid J. R., Eble J. N., Lescoe M. K., Fishel R., Kelley M. R.: "Differential cellular expression of the human MSH2 repair enzyme in small and large intestine". Cancer Res., 1996, 55, 5146.
10. Reitmair A. H., Cai J. C., Bjerknes M., Redston M., Cheng H., Pind M. T. L., Hay K. et al.: "MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis". Cancer Res., 1996, 56, 2922.
11. Leach F. S., Polyak K., Burrell M., Johnson K. A., Hill D., Dunlop M. G., Wyllie A. H. et al.: "Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissue". Can Res., 1996, 56, 235.
12. Rubin S. C., Blackwood M. A., Bandera C., Behbakht K., Benjamin I., Rebbeck T. R., Boyd J.: "BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Relationship to family history and implications for genetic testing". Am. J. Obstet. Gynecol., 1998, 178, 670.
13. Fink D., Nebel S., Norris P. S., Baergen R. N., Wilczynski S. P., Costa M. J., Haas M. et al.: "Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin". Int. J. Cancer, 1998, 77, 741.
14. Brown R., Hirst G. L., Gallagher W. M., McIlwrath A. J., Margison G. P., van der Zee A. G. J., Anthoney D. A.: "HMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents". Oncogene, 1997, 15, 45.